Net Cash Provided by (Used in) Financing Activities of NEUROONE MEDICAL TECHNOLOGIES Corp from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Dec 2025 was $147,823.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Net Cash Provided by (Used in) Financing Activities for 2025 was $8,029,354, a 10% increase from 2024.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Net Cash Provided by (Used in) Financing Activities for 2024 was $7,269,586, a 1.8% decline from 2023.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $7,399,074, a 38% decline from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $147,823 +$657,148 01 Oct 2025 31 Dec 2025 10-Q 17 Feb 2026 2026 Q1
Q4 2024 $509,325 -$1,714,339 -142% 01 Oct 2024 31 Dec 2024 10-Q 17 Feb 2026 2026 Q1
Q4 2023 $1,205,014 +$1,220,727 01 Oct 2023 31 Dec 2023 10-Q 12 Feb 2025 2025 Q1
Q4 2022 $15,713 -$12,039,317 -100% 01 Oct 2022 31 Dec 2022 10-Q 13 Feb 2024 2024 Q1
Q4 2021 $12,023,604 +$7,026,657 +141% 01 Oct 2021 31 Dec 2021 10-Q 13 Feb 2023 2023 Q1
Q4 2020 $4,996,947 +$1,978,277 +66% 01 Oct 2020 31 Dec 2020 10-Q 14 Feb 2022 2022 Q1
Q4 2019 $3,018,670 +$1,981,670 +191% 01 Oct 2019 31 Dec 2019 10-Q 16 Feb 2021 2021 Q1
Q4 2018 $1,037,000 +$390,449 +60% 01 Oct 2018 31 Dec 2018 10-Q 14 Feb 2020 2020 Q1
Q1 2018 $590,000 +$274,880 +87% 01 Jan 2018 31 Mar 2018 10-Q 16 May 2018 2018 Q1
Q4 2017 $646,551 01 Oct 2017 31 Dec 2017 10-Q 14 Feb 2019 2019 Q1
Q1 2017 $315,120 01 Jan 2017 31 Mar 2017 10-Q 16 May 2018 2018 Q1
Q1 2013 $7,000 01 Jan 2013 31 Mar 2013 10-Q 15 May 2013 2013 Q1

NEUROONE MEDICAL TECHNOLOGIES Corp Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $8,029,354 +$759,768 +10% 01 Oct 2024 30 Sep 2025 10-K 17 Dec 2025 2025 FY
2024 $7,269,586 -$129,488 -1.8% 01 Oct 2023 30 Sep 2024 10-K 17 Dec 2025 2025 FY
2023 $7,399,074 -$4,624,208 -38% 01 Oct 2022 30 Sep 2023 10-K 17 Dec 2024 2024 FY
2022 $12,023,282 +$488,428 +4.2% 01 Oct 2021 30 Sep 2022 10-K 15 Dec 2023 2023 FY
2021 $11,534,854 +$4,211,477 +58% 01 Oct 2020 30 Sep 2021 10-K 22 Dec 2022 2022 FY
2020 $7,323,377 +$1,556,579 +27% 01 Oct 2019 30 Sep 2020 10-K/A 31 May 2022 2021 FY
2019 $5,766,798 01 Oct 2018 30 Sep 2019 10-K 09 Dec 2020 2020 FY
2017 $1,704,032 01 Jan 2017 31 Dec 2017 10-KT 18 Mar 2019 2018 FY
2012 $1,000,000 +$967,850 +3010% 01 Jan 2012 31 Dec 2012 10-K 11 Apr 2013 2012 FY
2011 $32,150 +$19,150 +147% 01 Jan 2011 31 Dec 2011 10-K 11 Apr 2013 2012 FY
2010 $13,000 01 Jan 2010 31 Dec 2010 10-K 28 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.